Pertussis
📧 Sign up to get email alerts when something new happens for Pertussis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Clinical Study to Assess the Immunogenicity and Safety of Hexavalent Vaccine Containing Reduced Dose IPV [Phase 3]
This document reports a Phase 3 clinical trial evaluating the immunogenicity and safety of a hexavalent vaccine that contains a reduced-dose…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: The Optimal Timing of Vaccination in Pregnancy
This clinical trial update discusses ongoing studies to determine the optimal timing of pertussis vaccination during pregnancy. Recruitment …
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women [Phase 4]
A Phase 4 clinical trial update on pertussis vaccination in HIV-infected and HIV-uninfected pregnant women using the DTaP vaccine. The study…
-
CLINICAL_TRIALS research · 2024-05-24Clinical Trial Update: Impact of Bacterial Expression and Immune Response in the Severity of Pertussis [NA]
A clinical trial sponsored by Institut Pasteur is investigating how bacterial expression and immune response influence the severity of pertu…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia [NA]
Clinical trial registry entry for evaluating the LIAISON NES diagnostic assay for Influenza A/B, RSV, and COVID-19 in symptomatic patients i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of a diphtheria, tetanus, and pertussis vaccine in 3-month-old infants; currently …
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Maternal Pertussis Wholecell Responses [Phase 2]
Phase 2 clinical trial update assessing maternal pertussis whole-cell responses has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Vaxelis™ in Children Previously Vaccinated With Vaxelis™ or Hexyon™ (V419-016) [Phase 4]
Phase 4 study assessing safety, tolerability, and immunogenicity of the hexavalent vaccine Vaxelis in children previously vaccinated with Va…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Phase 3]
Phase 3 trial update for a diphtheria-tetanus-acellular pertussis-inactivated poliovirus combination vaccine were completed.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults [Phase 2]
Phase 2 trial update for BPZE1 intranasal pertussis vaccine (Prime + Boost) in healthy adults; study completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating the immunogenicity and safety of LBVD(Hexavalent Vaccine) in healthy infants as part of the primary seri…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants [Phase 2]
A Phase 2 clinical trial evaluating the safety and immunogenicity of the Boostrix vaccine in pregnant Malian women and their infants, with r…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants [Phase 3]
Phase 3 trial comparing primary and booster DTaP-IPV-Hib vaccinations to co-administration of DTaP-IPV and Hib in Japanese infants; study co…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth [Phase 3]
Phase 3 trial update evaluating the immunogenicity and safety of Sanofi Pasteur's combined vaccine given as a three-dose primary series in i…
-
CLINICAL_TRIALS trial_result · 2022-04-05Clinical Trial Update: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants [Phase 3]
Phase 3 clinical trial evaluating DTaP-IPV-HB-PRP-T as a primary series and a second-year booster in HIV-exposed infants (infected and uninf…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Gambia Pertussis Study (GaPs) [Phase 4]
Phase 4 clinical trial update for pertussis in Gambia (GaPs) sponsored by London School of Hygiene and Tropical Medicine.
-
CLINICAL_TRIALS trial_result · 2022-02-03Clinical Trial Update: Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults [Phase 2]
Phase 2 results report on the safety and immunogenicity of intranasal BPZE1 vaccination in healthy adults for pertussis. The trial has compl…
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines [Phase 2, Phase 3]
A trial evaluating safety and immunogenicity of 2 doses versus 1 dose of acellular pertussis vaccines containing genetically-detoxified pert…
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Pertussis Vaccination in Pregnant Women [Phase 4]
Phase 4 clinical trial update on pertussis vaccination in pregnant women has been completed.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Optimising the Timing of Whooping Cough Immunisation in MUMs [Phase 4]
Phase 4 trial update focused on optimizing the timing of pertussis (whooping cough) immunization during pregnancy.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: A Study Exploring Whooping Cough Protection in Children and Adults [Phase 4]
Phase 4 clinical trial update on pertussis protection in children and adults.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Boostrix® Pregnancy Registry
Clinical Trial Update for Boostrix Pregnancy Registry reports completed study with posted results for pertussis exposure during pregnancy.
-
CLINICAL_TRIALS trial_result · 2020-11-06Clinical Trial Update: To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years [Phase 3]
Phase 3 trial update evaluating immunogenicity and safety of DTaP-IPV vaccine as a booster in healthy children aged 4-6 years.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Adacel® Booster Vaccination for CMI Assay Development [Phase 4]
Phase 4 clinical trial update evaluating Adacel booster vaccination for CMI assay development in pertussis.